News About Hospital

 

Hirslanden hospitals dropped by two private insurers

Two of Switzerland's biggest private health insurers have taken a handful of Mediclinic International's Swiss subsidiary Hirslanden's hospitals off their provider list. We talk to the insurers and market sources about what this means for the hospital sector.

Mid Europa to put Regina Maria up for sale this summer?

Romanian Healthcare group Regina Maria looks like it will trade in 2019, with owners Mid Europa close to appointing a sell-side advisor and a decision possibly due this summer, HBI hears. We look at it in the context of private equity investments across Europe's hospital sector.

Finally, progress on Acibadem’s Bulgaria sale

Five months after the IHH-owned Turkish hospital group's Bulgarian and Macedonian assets were put up for sale, a deal finally looks in the making with two investors in late-stage discussions to buy the Bulgarian business, we are told.

Medgate talks about its Rhoen JV

Last month we reported that Medgate had moved into Germany through a JV with the country's fourth largest hospital group. We caught up with the company to discuss models, reimbursement and the market. 

Mayo Clinic denies UAE hospital management deal

HBI hears rumour that Mayo Clinic, one of the biggest global brands in healthcare, is about to close an agreement with the Abu Dhabi government to manage a 700-bed hospital. Mayo tells HBI unequivocally this is not correct. 

Dispatches from Arab Health

Arab Health never seems to get any smaller. HBI travelled to Dubai and spoke to some of the 84,500 attendees and 4,150 exhibiting companies. But, strip out the hoop-la, and what is really going on at ground level? Here are our main takeaways from the four-day long event:

IPOs no-show as market slows

Two of Europe’s biggest healthcare companies which were widely expected to IPO imminently are now, we hear, ruling out this year. Why the delay – and what does this tell us about the state of a slowing market? HBI speaks to an operator CEO and investment banking sources.

Brazilian healthcare reform: As easy as “changing a flat tyre on a moving car”

Despite widespread global criticism for his politics, president Jair Bolsonaro has inspired confidence in the private sector. The Brazilian stock market Bovespa reached record highs last week after climbing steadily for the last six months. Why is private healthcare not seeing more benefit, and how does it need to reform? We speak to two experts in Brazilian healthcare to find out more.

Abraaj hospital enters Lagos market as mandatory insurance launches

We talk to the advisor behind the largest ever all-share merger in Nigeria's hospital sector, which recently closed, combining an Abraaj-owned group with a Lagos hospital. The deal coincides with the city's mandatory insurance rollout, a reform that could be helping to prompt a surge in new capacity where Nigeria most needs it.

Mandatory insurance in Bahrain could cause problems for large hospitals

Bahrain is due to follow its richer neighbour, the UAE, by implementing a mandatory insurance programme this year. Yet its far lower GDP and population could make it difficult for large hospitals to flourish in the region. HBI speaks to two GCC experts about how legislation will change the healthcare landscape.

San Donato looks set to IPO

Despite a generally weak hospital IPO market in Europe, Italy's largest hospital operator by revenue, Gruppo San Donato, looks set to list - perhaps prompted by the strong start the country's stock market has made to 2019.

Top 10 merger in Ukraine as hospital reform looms

Competition authorities are looking at an acquisition involving two of Ukraine's largest hospital players, a deal which a source tells us is in anticipation of the upcoming reforms that will put private and public hospitals on a level footing.

Elsan unlikely to trade before 2020

Despite rumours last year that CVC Capital Partners might be set to exit its large French hospital asset, we look at why this now seems unlikely -  and reveal which hospitals are performing the best and the group's EBITDA, together with a potential valuation.

Find Us